The costs on inaction on PrEP.
The Lancet Hiv
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D015658:HIV Infections / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D065129:Pre-Exposure Prophylaxis / Q000191:economics* / Q000331:legislation & jurisprudence; D013222:State Medicine / Q000191:economics / Q000331:legislation & jurisprudence; D006113:United Kingdom / Q000453:epidemiology
D019380:Anti-HIV Agents